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Lepidium  sativum  seed  (LSS)  (family:  Cruciferae)  has  been  used  in traditional  medicine  for the  treatment
of jaundice,  liver  problems,  spleen  diseases  and  gastrointestinal  disorders.  It  was also  reported  to  pos-
sess antihypertensive,  diuretic,  anti-asthmatic,  antioxidant,  and  anti-inﬂammatory  activities.  Attempt
has  been  made  to study  hepatoprotective  potential  of  LSS  available  in Saudi  Arabian  Market.  The  aim
of  the  present  study  was  to determine  the hepatoprotective  effect  of  ethanolic  extracts  of  LSS  against
carbon  tetrachloride  (CCl4) induced  acute  liver  injury  in  rats. The  bioactive  compounds  responsible  for
this activity  have  been  analyzed  by  GC–MS.
To  evaluate  the  hepatoprotective  activity,  six groups  (n  = 6) of rats  were  taken.  First  group  was  con-
trol,  second  was  toxic  and  other  groups  received  oral  test solutions:  100  mg/kg  silymarin,  or  LSS (100,
200,  and  400  mg/kg),  once  daily  for 7 consecutive  days,  followed  by  hepatotoxicity  induction  with CCl4.
Blood  and  liver  tissues  were  collected  for biochemical,  antioxidant  and microscopic  analyses.  The  bioac-
tive  constituents  present  in the  extract  were  analyzed  by  GC–MS.  Results  showed  that  pretreatment
with  LSS and silymarin  signiﬁcantly  reduced  the  level  of  serum  alanine  transaminase  (ALT),  aspartate
transaminase  (AST),  alkaline  phosphatase  (ALP)  and  bilirubin  (BIL),  which  was  increased  signiﬁcantly  in
toxic group  treated  with  only  CCl4. Histological  analysis  of liver  tissues  in  groups  pretreated  with  LSS
and  silymarin  showed  mild  necrosis  and  inﬂammation  of the hepatocytes  compared  to  the  toxic  group.
GC–MS  analysis  of  LSS  showed  the  presence  of  twelve  major  fatty  acids  including  alpha-linolenic  acid  as
a major  constituent.  These  results  indicated  that  LSS exerts  enhance  hepatoprotective  activity  that  could
be attributed  towards  its antioxidant  activity,  coupled  together  with  the  presence  of  anti-inﬂammatory
compounds  in  LSS  extract.
©  2015  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is an open  access  article  under  the CC. Introduction
Lepidium sativum Linn. (Family: Cruciferae) locally known as
El-Rshad” is a fast-growing, edible herb with tangy ﬂavor and
roma. In traditional system of medicine various parts of this plant
ave been used for the treatment of jaundice, liver problems,
pleen diseases, gastrointestinal disorders, menstrual problems,
racture, arthritis, and other inﬂammatory conditions [1–3]. The
eeds of L. sativum (LSS) are also used to cure throat diseases,
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O  Box 7897 (777-S), Riyadh 11159, Saudi Arabia. Fax: +966 1 4786601.
E-mail address: abdulrahman.alasmari@gmail.com (A.K. Al-Asmari).
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214-7500/© 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access
c-nd/4.0/).BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
asthma, headache, uterine tumour, nasal polyps and breast can-
cer [1]. Chemically, the seeds of L. sativum contain essential oils,
fatty oils, carbohydrate, protein, fatty acids, vitamins, ﬂavonoids
and isothiocynates glycoside [4]. Experimental evidences showed
that L. sativum has antihypertensive [5], diuretic [6], anti-asthmatic
[7], hypoglycaemic [8], antioxidant [4,9,10] and anti-inﬂammatory
[11] properties.
Due to reported antioxidant and anti-inﬂammatory activity, the
present study was  designed to investigate the protective effect
of LSS against CCl4 induced toxicity. Additionally, the compound
present in the extract was also investigated that could be respon-
sible for the activity of the extract.
Previously the hepatoprotective activity of LSS against CCl4 [12],
and doxorubicin [13] induced toxicity has been reported but as per
 article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
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Fig. 1. Effect of Lipidium sativum seed extract on serum marker enzymes (A) alanine transaminase (ALT), (B) aspartate transaminase (AST), (C) alkaline phosphatase (ALP),
and  (D) bilirubin (BIL) after CCl4 intoxication in rats. * Statistically signiﬁcant (P ≤ 0.05).
Control: animals with no treatment; toxic: animals receiving only CCl4; low dose: animals receiving ethanolic extract of the Lipidium sativum seed at a dose of 100 mg/kg
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thanolic extract of the L. sativum seed at a dose of 400 mg/kg followed by challengi
ith  CCl4.
ur knowledge no work has been done on the LSS available in Saudi
rabia. In addition to this, the novelty of this work is that the con-
tituent of the bioactive extract has been investigated that may  be
esponsible for the biological activity of the extract.
. Materials and methods
.1. Collection of plant materials
LSS were collected from local market of Riyadh, Kingdom of
audi Arabia and were stored in air tight containers.
.2. Preparation of the extract
The extraction was performed using Soxhlet apparatus. Sixty
rams of dried seeds were grinded into coarse powder. Coarsely
owdered seeds were taken and 600 mL  of ethanol was added. The
xtraction was continued for 6–8 h until all the soluble constituents
issolved in the solvent. The extract was ﬁltered and evaporated
n rotary evaporator (Buchi, Switzerland; temp: 60 ◦C; pressure
75 mbar) to yield semi solid masses. Extract thus obtained, were
ollected and stored at 4 ◦C until further use.
.3. Hepatoprotective activity of the extract
.3.1. Animals
Thirty six male Wistar rats (190–200 g) were provided by theentral animal house facility, Research Center, Prince Sultan Mili-
ary Medical City, Riyadh. They were kept in standard cages at room
emperature (25 ± 3 ◦C) with a 12 h dark–light cycle. They were
llowed to consume standard laboratory food and water. Rats werese of 200 mg/kg followed by challenging with CCl4; high dose: animals receiving
h CCl4; animals receiving silymarin at a dose of 100 mg/kg followed by challenging
equally divided into six groups. Group I was considered as control
and administered with olive oil of 1 mL/kg body weight (b.w.) via
the intraperitoneal route. Group II received 1 mL/kg b.w. of CCl4
(50% in olive oil) via the intraperitoneal route 24 h prior to sacriﬁce.
Groups III, IV and V were given 100 mg/kg b.w., 200 mg/kg b.w. and
400 mg/kg b.w. of LSS respectively via the oral route for one week.
Group VI received 100 mg/kg b.w. of silymarin for one week. All
animals except the control group were challenged with CCl4. After
24 h, the animals were sacriﬁced under mild anesthesia. The blood
was collected and used for biochemical analysis. Livers were also
removed and half of the liver was snapped freeze for enzymatic
analyses, whereas the other portion was processed for histological
analyses.
2.3.2. Assessment of levels of liver marker enzymes and
biochemical parameters
Serum analysis of various liver enzymes including alanine
transaminase (ALT), aspartate transaminase (AST), alkaline phos-
phatase (ALP) and Bilirubin (BIL) was  estimated using standard kits
(Human Diagnostics, Germany). Results are shown in Fig. 1A–D.
2.3.3. Assessment of Myeloperoxidase (MPO) enzyme
MPO  activity was assayed by the method of Bradley et al. [14].
Tissue homogenate was prepared in potassium phosphate buffer
(50 mM;  pH 6.0) containing hexadecyl–trimethyl ammonium bro-
mide (0.5%). Samples were subjected to three cycles of sonication
freeze-thaw process followed by centrifugation (@14000 rpm; 4 ◦C)
for 25 min. Supernatant was collected and to one hundred micro-
liter of supernatant, added 2.9 mL  phosphate buffer (50 mM,  pH
6.0) containing 0.167 mg/mL  o-dianisidine dihydrochloride and 1%
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ydrogen peroxide as substrates. Kinetics of MPO  activity was mea-
ured at 460 nm for three min. The result was shown in Fig. 2A.
.3.4. Assessment of Superoxide dismutase (SOD) enzyme
SOD activity was analyzed by the method of Marklund and
arklund [15]. Tissue homogenate was prepared in ice cold
ucrose solution (0.25 M;  pH 8.5) containing Triton x-100 (0.5%).
he homogenate solution was centrifuged (@17000 rpm; 4 ◦C) for
0 min. Supernatant was  collected for analysis. Five micro liter of
upernatant was added to 1395 L of ice cold sucrose solution
0.25 M;  pH 8.5) and 100 L of pyraogallol (2.6 mM)  containing Tris-
Cl. SOD activity was measured at 420 nm over 3 min. The results
ere presented in Fig. 2B.
.3.5. Histopathological study
For microscopic evaluation, liver samples were ﬁxed in a ﬁxative
formalin solution neutral buffered, 10%) and embedded in paraf-
n sectioned at 5 m thickness. The sections were subsequently
tained with Mayers’ hematoxylin and eosin (Sigma–Aldrich,
ermany). The stained samples were read under light microscope
t 10× magniﬁcation. The Slides were photographed, and docu-
ented in Fig. 3A–F.
.3.6. Statistical analyses
The data were analyzed by one way analysis of variance
ANOVA) using computer software Graph Prism, version 3.02
Graph Pad Software Inc, CA, USA) and statistically signiﬁcant
ffects were further analyzed by comparing means using Dunnett’s
est. The level of signiﬁcance was considered at P ≤ 0.05.
.4. Preliminary phytochemical screening of the plant
Preliminary phytochemical screening were carried out on the
SS using standard procedure to identify the phyto constituents as
escribed by Trease and Harborne [16–18].
.5. Gas chromatography–mass spectrometry (GC–MS) analysis
.5.1. Sample preparation for FAME (Fatty acid methyl ester)
nalysis
FAME sample was prepared as per modiﬁed method of Met-
alfe et al. [19]. Brieﬂy, one gram of extract was taken and added mL  of isooctane and 100 L of methanolic potassium hydroxide
olution (2 M).  The mixture was shaken/vortexed exactly for one
inute and allowed to settled down under gravity. Next, 2 mL  of
0 % (w/v) aqueous sodium chloride solution was  added into it. ThePO) and (B) superoxide dismutase (SOD) in liver tissues after CCl4 intoxication in
mixture was  again shaken brieﬂy and allowed the layers to be sep-
arated. Upper layer (isooctane layer) was  taken in another tube and
added a pinch of anhydrous sodium sulphate to remove moisture.
It was ﬁltered through 0.22 M ﬁlter and transferred to GC vial for
analysis.
2.5.2. Instrumentation for FAME analysis of LSS
GC–MS analysis were carried out in a GC system (Agilent 7890A
series, USA) equipped with split/splitless injector and auto-sampler
attached to an apolar 5-MS (5% phenyl polymethyl siloxane) capil-
lary column (Agilent 19,091S-43; 30 m × 0.25 mm i.d. and 0.25 m
ﬁlm thickness) and ﬁtted to mass detector (Agilent 5975C series,
USA). The ﬂow rate of the carrier gas, helium (He) was set to be
at 1 mL  min−1, split ratio was 1:50. The injector temperature was
adjusted at 250 ◦C, while the detector temperature was ﬁxed to
280 ◦C. The column temperature was kept at 40 ◦C for 1 min  fol-
lowed by linear programming to raise the temperature from 40◦
to 120 ◦C (at 4 ◦C min−1 with 2 min  hold time), 120 ◦C to 170 ◦C
(at 6 ◦C min−1 with 1 min  hold time) and 170 ◦C to 200 ◦C (at
10 ◦C min−1 with 1 min  hold time). The transfer line was heated
at 280 ◦C. Two  microliter of FAME sample was  injected for analysis.
Mass spectra were acquired in scan mode (70 eV); in the range of
50–550 m/z. The chromatogram is presented in Fig. 4.
2.5.3. Identiﬁcation of compounds
Interpretation of mass spectrum was conducted using the
database of National Institute of Standards and Technology (NIST,
USA). The database consists of more than 62,000 patterns of known
compounds. The spectrum of the extract was matched with the
spectrum of the known components stored in the NIST library.
3. Results
3.1. Hepatoprotective activity of LSS
3.1.1. Effect of LSS on parameters of liver markers enzymes
As shown in Fig. 1A–D, administration of CCl4 markedly
increased the activity of liver enzymes AST, ALT, ALP and biliru-
bin as compared to the control group. Secretion of these enzymes
was found signiﬁcantly low (P ≤ 0.05) due to the treatment of LSS
and silymarin as compared to the CCl4 group.3.1.2. Effect of the plant extract on parameters of oxidative stress
in the liver
The activity of MPO  in various concentrations of LSS pretreated
rats and silymarin was  signiﬁcantly decreased as compared to the
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Fig. 3. Photomicrographs of histological changes of rat liver at magniﬁcation of 10×.  (A) normal control showed well maintained histology of rat liver. (B) CCl4 treated rats
showed,  fatty changes, necrosis, nuclear and lobular degeneration and inﬂammation of the cells. (C) LSE (100 mg/kg, p.o.) + CCl4 (1.0 mL/kg in olive oil 1:1, i.p.) treated group
showed less nuclear degeneration as compared to toxic group. (D) LSE (200 mg/kg, p.o.) + CCl4 (1.0 mL/kg in olive oil 1:1, i.p.) treated rat liver showed improved structure
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tructure. (F) Silymarin (100 mg/kg, p.o.) + CCl4 (1.0 mL/kg in olive oil 1:1, i.p.) treat
n  each group. Scoring was performed as follows; scale: 1–100; 1: minimum deform
roup of rats treated with CCl4 only (Fig. 2A). In addition to this, the
ctivity of SOD was also found to be signiﬁcantly low when treated
ith CCl4. Furthermore, treatment of rats with various concentra-
ions of LSS and silymarin (100 mg/kg b.w.) in combination with
Cl4 signiﬁcantly maintained the levels of antioxidant enzymes as
tated above (Fig. 2B).
.1.3. Histopathological study
The livers of the normal control rats showed normal histo-
ogical architecture as shown in Fig. 3A. The liver sections of
ormal rats showed the presence of distinct hepatic cells with
ell-preserved cytoplasm, prominent nucleus, hepatocytes radi-
lly arranged around the central vein, and well-deﬁned sinusoidal
ine. However, the section of rats treated with CCl4 showed necrosis,
evere cytoplasmic vacuolation, microvesicular and macrovesic-
lar fatty changes, loss of cellular boundaries, inﬁltration of
nﬂammatory cells around the central vein and in the portal areas
nd congestion in the sinusoids (Fig. 3B). These observations were
arkedly ameliorated in the groups of rats which were pretreated
ith LSS or silymarin indicating a signiﬁcant reduction in the
umber of degenerated hepatocytes and a signiﬁcant decrease
n necrosis (Fig. 3C–F). In the group of animals pretreated with
00 mg/kg of LSS followed by CCl4 administration, showed less
uclear degeneration as compared to toxic group. Inconspicu-
us fatty acid changes and inﬁltration of lymphocytes and spotty
nd focal necrosis were observed (Fig. 3C). Pretreatment with
00 mg/kg of LSS followed by CCl4 administration showed rescue
n structural architects with moderate nuclear degeneration, some, i.p.) treated rat liver showed minimum fatty acid changes and retain the general
liver showed preserved cell architecture. (G) Graph showing the level of deformity
d 100: maximum deformity.
fatty layer changes and mild leucocytes inﬁltration around the cen-
trilobular region (Fig. 3D). The group which was  pretreated with
400 mg/kg LSS showed minimum fatty acid changes, mild nuclear
degeneration and slight necrosis. Overall this group retained the
original structure of hepatocytes (Fig. 3E). The group pretreated
with 100 mg/kg silymarin was devoid of any structural alteration as
compared to toxic group and retain the normal cellular architecture
(Fig. 3F). The histopatholgical scoring of all the groups are shown
in Fig. 3G. Scoring was  performed on the scale of 1–100; consid-
ering 1 as minimum deformity and 100 as maximum deformities
in hepatocytes in terms of fatty layer changes, necrosis, nuclear
degeneration, lobular degeneration and inﬂammation of the cells.
To sum-up the histological ﬁndings, our results showed that the
LSS extract as well as silymarin remarkably decrease the signs of
CCl4-induced toxicity.
3.2. Preliminary phytochemical screening
Preliminary phytochemical screening of LSS revealed the pres-
ence of alkaloids, carbohydrates, saponins, tannins, phenolics and
ﬂavonoids. Interestingly, the glycosides were found to be absent.
3.3. GC–MS analysis of LSSLSS proﬁle obtained on GC–MS showed 12 major fatty acids
namely tetradecanoic acid (myristic acid), 9-hexadecenoic acid
(palmitoleic acid), hexadecanoic acid (palmitic Acid), 9,12,15-
octadecatrienoic acid (alpha-linolenic acid), octadecenoic acid
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Table 1
Compounds present in ethanolic extract of Lepidium sativum seed.
S. No. RTa Formula RPb IUPAC
name
Common name LNc Chemical structure
1 12.54 C14H28O2 0.1 Tetradecanoic
acid
Myristic acid C14:0
2 15.56 C16H30O2 0.22 9-
Hexadecenoic
acid,
Palmitoleic
acid
C16:1
3 15.95 C16H32O2 8.54 Hexadecanoic
acid,
Palmitic acid C16:0
4 18.84 C18H30O2 55.47 9,12,15-
Octadecatrienoic
acid,
Alpha-linolenic
acid
C18:3
5 19.07 C18H36O2 3.29 Octadecenoic
acid
Stearic acid C18:0
6 21.22 C18H32O2 0.84 9-Octadecen-
12-ynoic
acid
NA C18:2
7 21.60 C20H38O2 14.21 Cis-13-
eicosenoic
acid
Paullinic acid
(omega-7 fatty
acid)
20:1
8 21.91 C20H40O2 4.16 Eicosanoic acid Arachidic acid 20:0
9 24.24 C22H42O2 5.65 13-Docosenoic
acid
Erucic acid
(monounsatu-
rated omega-9
fatty acid)
22:1
10 24.53 C22H44O2 1.34 Docosanoic
acid
Behenic acid 22:0
11 26.75 C24H46O2 1.15 15-
Tetracosenoic
acid
Nervonic acid
(monounsaturated
omega-9 fatty
acid)
24:1
12 27.07 C24H48O2 0.84 Tetracosanoic
acid
Lignoceric acid 24:0
a Retention time.
b Relative percentage.
c Lipid numbers.
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Fig. 4. GC–MS analyses of Lepidium sativum extract. Typical TIC-GC/MS chromatogram of L. sativum seed extract analyzed on GC system (Agilent 7890A series, USA) equipped
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fter  comparing with the spectra in NIST Library, It showed the presence of twelve
stearic acid), 9-octadecen-12-ynoic acid, cis-13-eicosenoic acid
paullinic acid), eicosanoic acid (arachidic acid), 13-docosenoic acid
erucic acid), docosanoic acid (behenic acid), 15-tetracosenoic acid
nervonic acid) and tetracosanoic acid (lignoceric acid) (Fig. 4). The
etention time, chemical/formulae and chemical structures of all
atty acids found in LSS are depicted in Table 1.
. Discussion
Liver disease is becoming an important public health concerns
ue to rising incidence of obesity in all age groups [20]. The disease
ffects millions of the people in the United Sates [21]. The conven-
ional treatments of hepatic problems, such as cirrhosis, fatty liver
nd chronic hepatitis, are frequently inadequate due to adverse
ffects caused by hepatotoxic chemical drugs [22]. To overcome this
roblems, medicinal plants, due to their natural richness in hepato-
rotective compounds, have been extensively studied to cure the
iver ailments.-43; 30 m × 0.25 mm i.d. and 0.25 m ﬁlm thickness) attached with mass detector.
ounds.
In the present study, hepatoprotective activity of ethanolic
extract of L. sativum was investigated using hepatotoxic model
induced by CCl4.
In biological system, CCl4 is activated by cytochrome P-450
dependent mixed oxidase in the endoplasmic reticulum to form
trichloromethyl free radical (.CCl3 and .Cl3COO). This leads to
changes in the endoplasmic reticulum and other membrane hence
to increase in plasma membrane permeability to calcium ion
resulting in a severe disturbances of calcium homeostasis and con-
sequently necrotic cell death [23,24]. Carbon tetrachloride causes
multi organ disorder including the fatty layer degeneration of liver
and centrilobular necrosis [25]. This phenomenon conﬁrms that
CCl4 is a potent hepatotoxin and can be used for the character-
ization of the liver disease curing medicines. The hepatotoxicity
of CCl4 is further evidenced by elevation of liver damaging mark-
ers enzymes (AST, ALT, APT and bilirubin), increased MPO  activity
in tissues and histopathological anomalies. Two of the marker
enzymes; namely AST and ALT which are present in the hepa-
tocyte can easily leaks into the blood stream once the liver cells
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[A.K. Al-Asmari et al. / Toxico
ere damaged [24]. A high level of AST indicates the loss of func-
ional integrity of the liver, which mimics the effects seen in viral
epatitis, cardiac infraction, and muscle injury. The ALT enzymes
atalyzes the conversion of alanine to pyruvate and glutamate and
s released from hepatocytes to blood in a similar manner as AST
26]. ALP catalyzes the hydrolysis of phosphate esters. Elevation of
LP indicates intrahepatic, extrahepatic biliary obstruction or inﬁl-
rative disease of the liver. Serum concentration of bilirubin is a
arker of the liver’s ability to take up bilirubin from the plasma into
he hepatocyte. Elevated level of serum bilirubin is duo its leakage
rom hepatocytes to plasma, usually because of hepatic obstruction
o bile outﬂow and cholestasis [27].
In this study, we assessed the hepatoprotective role of L. sativum
eed extract. The results suggested that pretreatment with LSS
xtract signiﬁcantly restored the liver damaging marker enzymes,
ence conﬁrming its hepatoprotective potential. Our results are in
ccordance with the previously published work by Afaf et al. [12]
here they reported the role of LSS as hepatoprotective agent. In
ur study we  found the improved histological structure in extract
reated group that also supports the hepatoprotective effect of the
LS.
Although the exact molecular mechanism of action of LSS is not
ully understood, however, Lee et al. [28] have reported the role of
SS in preventing oxidative stress related liver damage. This noble
nding could be attributed towards the presence of phenolic com-
ound in the LSS extract. Similar to this ﬁnding our preliminary
hytochemical screening studies also showed the presence of phe-
olic compound in the extract which we have used in this study.
ur ﬁndings correlates with the previous ﬁnding [28] and can be
inked to the same conclusion as the role of phenolic compounds
hich play signiﬁcant role in oxidative stress related liver damage.
Liver inﬂammation also plays an important role in drug induced
cute hepatitis [26]. In our study the histopathology of the LS
retreated group of rats showed less inﬂammation, well restored
epatocytes and less area of necrosis as compared to severe
ecrosis and inﬂammation in CCl4 treated group of animals.
hese ﬁndings suggest the possibility of the presence of anti-
nﬂammatory compounds in LSS extract which could also be a
ontributing factor towards the hepatoprotective action of LSS.
Our ﬁndings in the GC/MS analysis showed the presence of
ipid compounds including alpha linoleic acid which has anti-
nﬂammatory activity [29–32]. The role of alpha linoleic acid is to
own regulate the expression of inﬂammatory cytokines such as
L-6, IL-1 and TNF- [33]. We  have reported a signiﬁcant down
rained in hepatic tissues inﬂammation in the animal group treated
ith LSS extract. Therefore, our current ﬁndings can also be well
orrelated with the previous published work where alpha linoleic
cid showed anti- inﬂammatory effect [33].
. Conclusion
In brief, it can be concluded that L. sativum seed extract
xerts hepatoprotective activity that could be partly contributed
y its antioxidant activity and presence of antioxidant and anti-
nﬂammatory compounds like Alpha linoleic acid. However the
echanistic studies on underlying molecular signaling pathways,
ike effects of seed extract on inﬂammatory cytokines, redox
ensitive transcription factors including nuclear factor-kappa B
NF-kappaB) and NF-E2 related factor 2 (Nrf2) and apoptotic path-
ays can be further studied to understand the changes at molecular
evel. A detail study needs to be done for isolation and characteri-
ation of individual bioactive compounds followed by assessment
f its biological activity so that the constituents responsible and
he mechanism involved for the efﬁcacy of L. sativum seed as a
epatoprotective agent can be conﬁrmed.
[
[eports 2 (2015) 1319–1326 1325
Disclosure
The authors have no conﬂict of interest.
Acknowledgment
The authors thank the Research Center, Prince Sultan Mili-
tary Medical City (PSMMC) for providing all necessary facilities to
conduct this study. Authors also thank Mr.  Mohamed Ismail for
assisting in extract preparation, and Mr.  Kumar Pulamadan for bio-
chemical analysis.
References
[1] M.  Al-Yahya, J. Mossa, A. Ageel, S. Rafatullah, Pharmacological and safety
evaluation studies on Lepidium sativum L., seeds, Phytomedicine 1 (1994)
155–159.
[2] S. Ahsan, M.  Tariq, M.  Ageel, M.  Alyahya, A. Shah, Studies on some herbal
drugs used in fracture healing, Pharm. Biol. 27 (1989) 235–239.
[3] A.K. Al-Asmari, A.M. Al-Elaiwi, M.T. Athar, M.  Tariq, A. Al Eid, S.M. Al-Asmary,
A  review of hepatoprotective plants used in saudi traditional medicine, J.
Evid. Based Complement. Altern. Med. 2014 (2014).
[4] Y.C. Yadav, D.N. Srivastav, A.K. Seth, V. Saini, R. Balaraman, T.K. Ghelani,
In  vivo antioxidant potential of Lepidium sativum seeds in albino rats using
cisplatin induced nephrotoxicity, Int. J. Phytomed. 2 (2010) 292–298.
[5] M.  Maghrani, N.-A. Zeggwagh, J.-B. Michel, M.  Eddouks, Antihypertensive
effect of Lepidium sativum L. in spontaneously hypertensive rats, J.
Ethnopharmacol. 100 (2005) 193–197.
[6] U. Patel, M.  Kulkarni, V. Undale, A. Bhosale, Evaluation of diuretic activity of
aqueous and methanol extracts of Lepidium sativum garden cress (Cruciferae)
in  rats, Trop. J. Pharm. Res. 8 (2009).
[7] A.N. Paranjape, A.A. Mehta, A study on clinical efﬁcacy of Lepidium sativum
seeds in treatment of bronchial asthma, Iran. J. Pharmacol. Ther. 5 (2006)
55–59.
[8] A. Patole, V. Agte, M.  Phadnis, Effect of mucilaginous seeds on in vitro rate of
starch hydrolysis and blood glucose levels of NIDDM subjects with special
reference to garden cress seeds, J. Med. Aromat. Plant Sci. 20 (1998)
1005–1008.
[9] M.  Zia-Ul-Haq, S. Ahmad, L. Calani, T. Mazzeo, D. Del Rio, N. Pellegrini, V. De
Feo,  Compositional study and antioxidant potential of Ipomoea hederacea Jacq.
and  Lepidium sativum L. seeds, Molecules 17 (2012) 10306–10321.
10] J. Agarwal, D.L. Verma, Antioxidant activity-guided fractionation of aqueous
extracts from Lepidium sativum and identiﬁcation of active ﬂavonol
glycosides, Acad. Arena 3 (2011) 14–18.
11] N.D. Raval, B. Ravishankar, B.K. Ashok, Anti-inﬂammatory effect of
Chandrashura (Lepidium sativum Linn.) an experimental study, AYU 34 (2013)
302–304.
12] I. Afaf, N.H. Abuelgasim, A. Mohammed, Hepatoprotective effect of Lepidium
sativum against carbon tetrachloride induced damage in rats, Res. J. Anim. Vet.
Sci. 3 (2008) 20–23.
13] E. Issabeagloo, Hepatoprotective effects of Lepidium Sativum on doxorubicin
mediated toxicity in rat, Magnt. Res. Rep. 2 (2014) 557–565.
14] P.P. Bradley, D.A. Priebat, R.D. Christensen, G. Rothstein, Measurement of
cutaneous inﬂammation: estimation of neutrophil content with an enzyme
marker, J. Invest. Dermatol. (1982) 206–209.
15] S. Marklund, G. Marklund, Involvement of the superoxide anion radical in the
autoxidation of pyrogallol and a convenient assay for superoxide dismutase,
Eur. J. Biochem. 47 (1974) 469–474.
16] G. Trease, W.  Evans, Pharmacognsy, in: Brailliar Tridel Can, 11th ed.,
Macmillan publishers, 1989, 2015.
17] J. Harborne, Phytochemical Methods a Guide to Modern Techniques of Plant
Analysis, JB Harborne, 1973.
18] H. Edeoga, D. Okwu, B. Mbaebie, Phytochemical constituents of some Nigerian
medicinal plants, Afr. J. Biotechnol. 4 (2005) 685–688.
19] L. Metcalfe, A.A. Schmitz, J. Pelka, Rapid preparation of fatty acid esters from
lipids for gas chromatographic analysis, Anal. Chem. 38 (1966) 514–515.
20] N.N. Than, P.N. Newsome, A concise review of non-alcoholic fatty liver
disease, Atherosclerosis 239 (2015) 192–202.
21] Anonymous, Liver Disease Overview, http://www.healthcommunities.com/
liver-disease/liver-disease-overview.shtml, in: S.J. Swierzewski (Ed.), 2015.
22] C. Pereira, L. Barros, I.C. Ferreira, Extraction, identiﬁcation, fractionation and
isolation of phenolic compounds in plants with hepatoprotective effects, J.
Sci. Food Agric. (2015).
23] L.W. Weber, M.  Boll, A. Stampﬂ, Hepatotoxicity and mechanism of action of
haloalkanes: carbon tetrachloride as a toxicological model, Crit. Rev. Toxicol.
33  (2003) 105–136.
24] S.I. Alqasoumi, M.S. Abdel-Kader, Screening of Some Traditionally Used Plants
for their Hepatoprotective Effect, INTECH Open Access Publisher, 2012.
25] R.O. Recknagel, E.A. Glende, J.A. Dolak, R.L. Waller, Mechanisms of carbon
tetrachloride toxicity, Pharmacol. Ther. 43 (1989) 139–154.
26] R. Grespan, R.P. Aguiar, F.N. Giubilei, R.R. Fuso, M.J. Damião, E.L. Silva, J.G.
Mikcha, L. Hernandes, C. Bersani Amado, R.K.N. Cuman, Hepatoprotective
1 logy R
[
[
[
[
[
[
Endocrinol. Metab. 91 (2006) 439–446.
[33] T.D. Zhao, K.R. Etherton, P.J. Martin, S.G. Gillies, Dietary -linolenic acid326 A.K. Al-Asmari et al. / Toxico
effect of pretreatment with Thymus vulgaris essential oil in experimental
model of acetaminophen-induced injury, J. Evid. Based Complement. Altern.
Med. 2014 (2014).
27] K.M. Field, C. Dow, M.  Michael, Part I: liver function in oncology: biochemistry
and beyond, Lancet Oncol. 9 (2008) 1092–1101.
28] C.-C. Lee, S.-R. Shen, Y.-J. Lai, S.-C. Wu,  Rutin and quercetin, bioactive
compounds from tartary buckwheat, prevent liver inﬂammatory injury, Food
Funct. 4 (2013) 794–802.
29] P.C. Calder, Polyunsaturated fatty acids and inﬂammation, Prostaglandins
Leukot. Essent. Fatty Acids 75 (2006) 197–202.
30] L.S. Rallidis, G. Paschos, G.K. Liakos, A.H. Velissaridou, G. Anastasiadis, A.
Zampelas, Dietary -linolenic acid decreases C-reactive protein, serum
amyloid A and interleukin-6 in dyslipidaemic patients, Atherosclerosis 167
(2003) 237–242.eports 2 (2015) 1319–1326
31] E. Lopez-Garcia, M.B. Schulze, J.E. Manson, J.B. Meigs, C.M. Albert, N. Rifai,
W.C. Willett, F.B. Hu, Consumption of (n-3) fatty acids is related to plasma
biomarkers of inﬂammation and endothelial activation in women, J. Nutr. 134
(2004) 1806–1811.
32] L. Ferrucci, A. Cherubini, S. Bandinelli, B. Bartali, A. Corsi, F. Lauretani, A.
Martin, C. Andres-Lacueva, U. Senin, J.M. Guralnik, Relationship of plasma
polyunsaturated fatty acids to circulating inﬂammatory markers, J. Clin.inhibits proinﬂammatory cytokine production by peripheral blood
mononuclear cells in hypercholesterolemic subjects, Am. J. Clin. Nutr. 85
(2007) 385–391.
